ARYZALERA 30mg tablets medication leaflet

N05AX12 aripiprazole • Nervous system | Antipsychotics | Other antipsychotics

Aripiprazole is an atypical antipsychotic used in the treatment of schizophrenia, bipolar disorder, and, in some cases, treatment-resistant major depression. It acts as a partial agonist of dopamine D2 and serotonin 5-HT1A receptors, as well as an antagonist of 5-HT2A receptors, helping to balance neurotransmitters in the brain.

Aripiprazole is available in tablet form, oral solutions, and long-acting injectable formulations. It is commonly used to reduce psychotic symptoms such as hallucinations and delusions and to stabilize mood in affective disorders.

Common side effects include nausea, dizziness, insomnia, and weight gain. In rare cases, severe adverse reactions such as neuroleptic malignant syndrome or tardive dyskinesia may occur.

Aripiprazole is an essential medication for managing psychiatric disorders, helping to improve patients' quality of life by reducing symptoms and preventing relapses.

General data about ARYZALERA 30mg

Substance: aripiprazole

Date of last drug list: 01-07-2015

Commercial code: W61494010

Concentration: 30mg

Pharmaceutical form: tablets

Quantity: 100

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA

Holder: KRKA, D.D., NOVO MESTO - SLOVENIA

Number: 11821/2019/10

Shelf life: 3 years

Concentrations available for aripiprazole

10mg, 15mg, 1mg/ml, 20mg, 30mg, 400mg, 5mg, 7.5mg/ml, 960mg